| Attribute |
Value |
| 52 Week Change |
0.48913038 |
| Address1 |
Building C14 |
| Address2 |
4th Floor No. 218, Xinghu Street Suzhou Industrial Park |
| All Time High |
31.83 |
| All Time Low |
0.9 |
| Ask |
4.0 |
| Ask Size |
3 |
| Average Analyst Rating |
1.0 - Strong Buy |
| Average Daily Volume10 Day |
414,150 |
| Average Daily Volume3 Month |
263,910 |
| Average Volume |
263,910 |
| Average Volume10Days |
414,150 |
| Beta |
0.537 |
| Bid |
2.56 |
| Bid Size |
2 |
| Book Value |
1.332 |
| City |
Suzhou |
| Country |
China |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
2.5479 |
| Current Ratio |
5.023 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
2.73 |
| Day Low |
2.52 |
| Debt To Equity |
5.746 |
| Display Name |
Adagene |
| Dividend Yield |
0.0 |
| Earnings Timestamp End |
1,753,704,000 |
| Earnings Timestamp Start |
1,753,268,340 |
| Ebitda |
-21,952,354 |
| Ebitda Margins |
-2.3628 |
| Enterprise To Ebitda |
-3.585 |
| Enterprise To Revenue |
8.471 |
| Enterprise Value |
78,703,960 |
| Eps Forward |
-0.56 |
| Eps Trailing Twelve Months |
-0.37 |
| Esg Populated |
0 |
| Exchange |
NGM |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
3.4668 |
| Fifty Day Average Change |
-0.9189 |
| Fifty Day Average Change Percent |
-0.26505712 |
| Fifty Two Week Change Percent |
48.913036 |
| Fifty Two Week High |
4.85 |
| Fifty Two Week High Change |
-2.3021 |
| Fifty Two Week High Change Percent |
-0.4746598 |
| Fifty Two Week Low |
1.3 |
| Fifty Two Week Low Change |
1.2479 |
| Fifty Two Week Low Change Percent |
0.95992315 |
| Fifty Two Week Range |
1.3 - 4.85 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,612,881,000,000 |
| Float Shares |
42,094,177 |
| Forward Eps |
-0.56 |
| Forward P E |
-4.5498214 |
| Free Cashflow |
-12,158,853 |
| Full Exchange Name |
NasdaqGM |
| Full Time Employees |
128 |
| Fullday Change |
-0.19210005 |
| Fullday Change Percent |
-7.0109506 |
| Fullday Price |
2.5479 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
1.0 |
| Gross Profits |
9,290,815 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.113929994 |
| Held Percent Institutions |
0.36044 |
| Implied Shares Outstanding |
67,143,344 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Ipo Expected Date |
2,021-02-09 |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Long Business Summary |
Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China. Its lead product candidate is the ADG126, a masked fully-human anti-CTLA-4 mAb which is in phase 1b/2 clinical development for the treatment of cancer. The company also develops ADG116, a fully human anti-CTLA-4 antibody generated using NEObody technology, which is in phase 1b/2 clinical trials to treat advanced/metastatic solid tumors; ADG206, which is in phase 1 clinical development to treat advanced metastatic solid tumors; ADG104, anti-PD-L1 monoclonal antibody which is in phase 2 clinical development; and ADG125, a novel anti-CSF-1R mAb which is in Phase 2 clinical development. In addition, it is developing ADG138, a HER2xCD3 POWERbody which is in pre clinical trial to treat low expressing tumors, as well as resistant/refractory tumors; ADG152, a CD20xCD3 POWERbody which is in preclincal trial to treat off-tumor toxicities; ADG153, a masked anti-CD47 IgG1 SAFEbody, wihx is in preclinical trial for the treatment of hematologic and solid tumor; and CD28 T-cell engagers, an anti-CD28 bispecific POWERbody TCEs to treat solid tumors. Adagene Inc. was incorporated in 2011 and is headquartered in Suzhou, China. |
| Long Name |
Adagene Inc. |
| Market |
us_market |
| Market Cap |
171,074,528 |
| Market State |
REGULAR |
| Max Age |
86,400 |
| Message Board Id |
finmb_118162960 |
| Most Recent Quarter |
1,782,777,600 |
| Net Income To Common |
-20,511,004 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
198,072,864 |
| Number Of Analyst Opinions |
6 |
| Open |
2.73 |
| Operating Cashflow |
-19,247,964 |
| Operating Margins |
-10.23915 |
| Phone |
86 512 8777 3632 |
| Previous Close |
2.74 |
| Price Hint |
4 |
| Price To Book |
1.9128377 |
| Price To Sales Trailing12 Months |
18.413296 |
| Profit Margins |
-2.20766 |
| Quick Ratio |
4.858 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
strong_buy |
| Recommendation Mean |
1.0 |
| Region |
US |
| Regular Market Change |
-0.19210005 |
| Regular Market Change Percent |
-7.0109506 |
| Regular Market Day High |
2.73 |
| Regular Market Day Low |
2.52 |
| Regular Market Day Range |
2.52 - 2.73 |
| Regular Market Open |
2.73 |
| Regular Market Previous Close |
2.74 |
| Regular Market Price |
2.5479 |
| Regular Market Time |
1,791,917,064 |
| Regular Market Volume |
123,241 |
| Return On Assets |
-0.13954 |
| Return On Equity |
-0.28504 |
| Revenue Per Share |
0.179 |
| Sand P52 Week Change |
0.17502642 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
67,143,344 |
| Shares Percent Shares Out |
0.0315 |
| Shares Short |
2,114,139 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
2,072,241 |
| Short Name |
Adagene Inc. |
| Short Percent Of Float |
0.037 |
| Short Ratio |
8.51 |
| Source Interval |
15 |
| Symbol |
ADAG |
| Target High Price |
17.45 |
| Target Low Price |
7.0 |
| Target Mean Price |
9.90833 |
| Target Median Price |
8.5 |
| Total Cash |
127,909,840 |
| Total Cash Per Share |
1.905 |
| Total Debt |
6,091,037 |
| Total Revenue |
9,290,815 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-0.37 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
3.37608 |
| Two Hundred Day Average Change |
-0.8281801 |
| Two Hundred Day Average Change Percent |
-0.24530819 |
| Type Disp |
Equity |
| Volume |
123,241 |
| Website |
https://www.adagene.com |
| Zip |
215,123 |